Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

ClinicalTrials.gov ID: NCT01526057

Public ClinicalTrials.gov record NCT01526057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A RANDOMIZED, DOUBLE-BLIND, STUDY COMPARING THE PHARMACOKINETICS AND PHARMACODYNAMICS, AND ASSESSING THE SAFETY OF PF-05280586 AND RITUXIMAB IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS ON A BACKGROUND OF METHOTREXATE WHO HAVE HAD AN INADEQUATE RESPONSE TO ONE OR MORE TNF ANTAGONIST THERAPIES

Study identification

NCT ID
NCT01526057
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
220 participants

Conditions and interventions

Interventions

  • PF-05280586 Biological
  • MabThera Biological
  • Rituxan Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 19, 2012
Primary completion
Aug 12, 2013
Completion
May 6, 2014
Last update posted
Nov 18, 2019

2012 – 2014

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
University of Alabama at Bermingham Birmingham Alabama 35249
University of Alabama at Birmingham - Arthritis Clinical Intervention Program (ACIP) SRC 076 Birmingham Alabama 35294
Rheumatology Associates of North Alabama, PC Huntsville Alabama 35801
ArthroCare, Arthritis Care & Research, PC Gilbert Arizona 85234
Mercy Clinic Hot Springs Communities Hot Springs Arkansas 71913
UCLA David Geffen School of Medicine Los Angeles California 90095-1670
Ronald Reagan UCLA Medical Center Los Angeles California 90095
Desert Medical Advances Palm Desert California 92260
Advances In Medicine Rancho Mirage California 92270
New England Research Assoc. LLC Trumbull Connecticut 06611
Arthritis Associates Orlando Florida 32804
University of South Florida - College of Medicine, Frank and Carol Morsani Center Tampa Florida 33612
Loyola Center for Health at Burr Ridge Burr Ridge Illinois 60527
Loyola Medical Medical Center Outpatient Center Maywood Illinois 60153
Loyola University Medical Center Pharmacy Maywood Illinois 60153
Illinois Bone and Joint Institute Morton Grove Illinois 60053
Loyola Center for health at Oakbrook Terrace North Oakbrook Terrace Illinois 60181
Bluegrass Community Research, Inc. Lexington Kentucky 40504
Klein & Associates, M.D., P.A. Cumberland Maryland 21502
Klein & Associates, M.D., P.A. Hagerstown Maryland 21740
Clinical Pharmacology Study Group Worcester Massachusetts 01605
UMass Memorial Medical Center - Memorial Campus Worcester Massachusetts 01605
UMass Memorial Medical Center-Rheumatology Center-Memorial Campus Worcester Massachusetts 01605
Bronson Internal Medicine & Rheumatology Battle Creek Michigan 49015
Rheumatology/Arthritis Center Lansing Michigan 48910
University Of Nevada School Of Medicine Las Vegas Nevada 89102
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
North Shore-LIJ Health System - Division of Rheumatology and Allergy-Clinical Immunology Great Neck New York 11021
Box Arthritis & Rheumatology of the Carolinas, PLLC Charlotte North Carolina 28210
Hickory Family Practice Associates Hickory North Carolina 28601
PMG Research of Hickory, LLC - PI's Main Office (Subject visit, IP Storage, Infusion, & Lab Draws) Hickory North Carolina 28602
PMG Research of Hickory Hickory North Carolina 28602
Cincinnati Rheumatic Disease Study Group, Inc. Cincinnati Ohio 45219
Health Research of Oklahoma Oklahoma City Oklahoma 73103
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
The Arthritis Group Philadelphia Pennsylvania 19152
Clinical Research Center of Reading, LLP Wyomissing Pennsylvania 19610
Arthritis Associates, PLLC Hixson Tennessee 37343
Arthritis Clinic Jackson Tennessee 38305
West Tennessee Research Institute Jackson Tennessee 38305
Metroplex Clinical Research Center Dallas Texas 75231
Center For Clinical Trials Of Houston Houston Texas 77004
Southwest Rheumatology Research LLC. Mesquite Texas 75150

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01526057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01526057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →